Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
31,681,355
-
Share change
-
-1,218,668
-
Total reported value
-
$50,056,171
-
Put/Call ratio
-
0.47%
-
Price per share
-
$1.58
-
Number of holders
-
35
-
Value change
-
-$2,246,325
-
Number of buys
-
9
-
Number of sells
-
22
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q1 2025
As of 31 Mar 2025,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,681,355 shares.
The largest 10 holders included
BVF INC/IL, TANG CAPITAL MANAGEMENT LLC, MORGAN STANLEY, BML Capital Management, LLC, Soleus Capital Management, L.P., Opaleye Management Inc., Pfizer Inc, Altium Capital Management LLC, BANK OF AMERICA CORP /DE/, and Aldebaran Capital, LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.